KRISTIE STINCHCOMB: Open Payments
NPI 1700454808 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 40 payments from 8 companies in 2025. Trend: 2023 $1,014 · 2024 $593 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $186 |
| Janssen Biotech, Inc. | 9 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $136 |
| Ardelyx, Inc. | 4 | $70 |
| QOL Medical, LLC | 3 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $21 |
Products named: TREMFYA, ENTYVIO, LINZESS, RINVOQ, IBSRELA, Sucraid, DUPIXENT, EOHILIA.
Industry payments across IN — which companies pay providers there.
